MINISO Group Q1 Adj. Profit Rises; Revenue Up 4.5%

MINISO Group Holding Limited (MNSO) reported first quarter adjusted net profit of RMB 417.4 million, an increase of 126.6% year over year. Adjusted net earnings per ADS was RMB 1.36 compared to RMB 0.60.

Profit for the period was RMB 404.1 million, an increase of 161.5% year over year. Earnings per ADS was RMB 1.32, compared to RMB 0.50.

Revenue was RMB 2.77 billion, an increase of 4.5% year over year, primarily driven by a 47.6% year-over-year growth of revenue from overseas markets, partially offset by a 8.8% year-over-year decrease of revenue from China.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Sohu.com Slips To Loss In Q3, Revenues Weak; Sees Loss In Q4 – Quick Facts

Sohu.com Limited (SOHU), a Chinese online media company, on Monday reported that third-quarter net loss attributable to the company was $22 million or $0.63 per ADS, compared to last year’s profit of $834.20 million or $21.06 per ADS.

Excluding last year’s $821.90 million gain from discontinues operations, net profit from continuing operations was $12.30 million or $0.31 per ADS.

Adjusted net loss attributable to Sohu.com Limited was $17 million or $0.50 per ADS, compared to net income of $17 million in 2021.

Total revenues were $185.27 million, down 14 percent from $216.09 million last year.

Brand advertising revenues were $26 million, down 24 percent year-over-year.

The company said it faced severe headwinds from the COVID-19 pandemic and uncertainties in the macroeconomic environment.

Looking ahead for the fourth quarter of 2022, Sohu estimates net loss attributable to be between $13 million and $23 million, and adjusted net loss attributable to be between $10 million and $20 million.

Brand advertising revenues would be between $25 million and $28 million, an annual decrease of 17 percent to 26 percent.

Online game revenues would be between $118 million and $128 million, an annual decrease of 11 percent to 18 percent.

Indivior To Buy Opiant For $145 Mln In Cash

Indivior Plc (INDV), and Opiant Pharmaceuticals, Inc. (OPNT), said on Monday that they have inked a deal to allow Indivior to acquire Opiant, for $20 per share or around $145 million in cash.

In addition, Indivior will pay $8 per share in contingent value rights or CVRs, payable following certain net revenue milestones achievements by OPNT003, an investigational opioid overdose reversal agent, during its approval and launch period.

Mark Crossley, CEO of Indivior, said: “Opiant’s portfolio of product candidates is an excellent strategic fit that diversifies and strengthens our offerings, while Indivior’s strong commercial capabilities are expected to propel a combined product pipeline with the potential to help patients along a continuum from substance use disorder and rescue to recovery.”

Indivior would also pay $2 CVR, if OPNT003 achieves certain net revenue thresholds. This means, Indivior will pay the additional total amount of $68 million, if OPNT003 achieves all those CVRs.

The acquisition is expected to add to Indivior’s earnings after the second full year of launch of OPNT003. The drug also has the potential to generate annual revenue of $150 million to $250 million.

Hamburger Hafen 9-month Earnings Fall, But Revenue Rises; Lifts Sales Outlook

Hamburger Hafen und Logistik AG (HHULF.PK,HHULY.PK), a German logistics and transportation firm, on Monday reported a decline in earnings for the first nine-month period to September, amidst higher energy prices, rising expenses, global supply chain disruptions, and war in Ukraine. However, the company recorded an increase in revenue.

In addition, for the full-year, the transporter has raised its sales outlook.

For the first nine-month period of 2022, the Hamburg-headquartered company posted earnings of 69.8 million euros, compared with 79.4 million euros a year ago. Operating result or EBIT stood at 160.1 million euros, lesser than 162.1 million euros of a year ago.

EBITDA, however, increased to 292.7 million from 290.1 million euros posted for the same period of 2021.

The Group generated revenues of 1.172 billion euros, higher than last year’s 1.078 billion euros.

Looking ahead, for the fiscal 2022, the company now projects a major increase in sales as against its previous expectation for a moderate increase.

For the full-year, the company still projects an operating result of 175 million euros to 210 million euros.

Orange Buys Two Swiss Cyber-security Firms

Orange (ORAN), a French telecom major, said on Monday that its cyber-security arm, Orange Cyberdefense, has acquired SCRT and Telsys, two Swiss sister firms with expertise in cyber-security and related services. The financial terms of the transaction were not disclosed.

The acquisition further enhances Orange Cyberdefense’s expertise in cyber threat intelligence, Orange in a statement.

Hugues Foulon, CEO of Orange Cyberdefense, commented, “…This is another step forward in our goal to establish ourselves as the European leader in cybersecurity. We are accelerating into the seventh cybersecurity market in Europe and thus consolidating the position of the Orange Group in the Swiss market”.

BioNTech To Acquire Manufacturing Site From Novartis Singapore To Develop MRNA Pipeline

BioNTech SE (BNTX) Monday announced an agreement with Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. to acquire one of its GMP-certified manufacturing facilities to develop mRNA-based vaccines and therapeutics.

The company said its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. has signed the agreement with Novartis and the acquisition will strengthen its global footprint in Asia. The facility will serve as BioNTech’s Regional Headquarters and become its first mRNA manufacturing facility in Singapore.

Supported by the Singapore Economic Development Board, the acquisition will help accelerate the establishment of a state-of-the-art mRNA manufacturing facility.